About Constance Chang
Form D filings for ONL Therapeutics from 2023 to 2024 list Constance Chang as executive officer.
Constance Chang first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Constance Chang in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Constance Chang works with at each company, as listed on that company's latest Form D.
ONL Therapeutics, Inc. · Form D, Sep 16, 2024
DE
David Esposito
CEO & President, director
AF
Aaron Fletcher
Director
MS
Michal Silverberg
Director
BB
Bill Burns
Director
DZ
David Zacks
Executive officer
MN
Marian Nakada
Director